相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Correlates of protection against SARS-CoV-2 in rhesus macaques
Katherine McMahan et al.
NATURE (2021)
Maturation and persistence of the anti-SARS-CoV-2 memory B cell response
Aurelien Sokal et al.
CELL (2021)
Waning Immunity after the BNT162b2 Vaccine in Israel
Yair Goldberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
Hiam Chemaitelly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine
Maria Prendecki et al.
LANCET (2021)
Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination
[Anonymous]
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
Florian Krammer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection
Federico Gobbi et al.
VIRUSES-BASEL (2021)
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine
Annalisa Ciabattini et al.
FRONTIERS IN IMMUNOLOGY (2021)
Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals
Mitnala Sasikala et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients
Juan Manuel Carreno et al.
EBIOMEDICINE (2021)
BNT162b2 vaccination induces durable SARS-CoV-2-specific T cells with a stem cell memory phenotype
Gisella Guerrera et al.
SCIENCE IMMUNOLOGY (2021)
Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers
Jean-Louis Bayart et al.
VACCINES (2021)
Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
Joseph E. Ebinger et al.
NATURE MEDICINE (2021)
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
Nicole Doria-Rose et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Distinct antibody and memory B cell responses in SARS-CoV-2 naive and recovered individuals after mRNA vaccination
Rishi R. Goel et al.
SCIENCE IMMUNOLOGY (2021)
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
Jackson S. Turner et al.
NATURE (2021)
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
S. J. Thomas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Covid-19: Third vaccine dose boosts immune response but may not be needed, say researchers
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2021)
Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study
Paul Naaber et al.
LANCET REGIONAL HEALTH-EUROPE (2021)
One dose of SARS-CoV-2 vaccine exponentially increases antibodies in individuals who have recovered from symptomatic COVID-19
Riccardo Levi et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
Ling Ni et al.
IMMUNITY (2020)
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Kizzmekia S. Corbett et al.
NATURE (2020)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J. Mulligan et al.
NATURE (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV-2-specific T cell responses and correlations with COVID-19 patient predisposition
Arne Sattler et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Phenotypical and functional specialization of FOXP3+ regulatory T cells
Daniel J. Campbell et al.
NATURE REVIEWS IMMUNOLOGY (2011)